Combined use of immunotherapy in a patient with kidney carcinoma: nine years later

Authors

  • Gustavo Frías Alvarez Hospital Héroes del Baire

Abstract

Background: kidney cells carcinoma therapy is characterized by a poor response to adjuvant treatment.
Objective:
to improve the free disease interval; global survive and quality of life.
Clinical case:
a sixty three- year-old patient with a right kidney carcinoma was operated in August 1998. In May, 2002 he was diagnosed with abdominal adenopathies. On November, 2002 he was operated again because of adrenal metastases. On December, 2006 he began combined immunotherapy obtaining a complete response of him for the time being.
Conclusions:
combined immunotherapy can be effective in the management of this type of tumor.
DeCS: CARCINOMA, RENAL CELL/therapy; DRUG THERAPY, COMBINATION; NEPHRECTOMY; MIDDLE AGED; CASE REPORTS.

Downloads

Download data is not yet available.

Author Biography

Gustavo Frías Alvarez, Hospital Héroes del Baire

Dpto Oncología

Oncólogo Clínico

Published

2016-12-08

How to Cite

1.
Frías Alvarez G. Combined use of immunotherapy in a patient with kidney carcinoma: nine years later. Arch méd Camagüey [Internet]. 2016 Dec. 8 [cited 2025 Aug. 18];20(6):710-5. Available from: https://revistaamc.sld.cu/index.php/amc/article/view/4743

Issue

Section

Case Reports